3643companies in the directory 1104ISIN verified against the check digit 7exchanges 14sectors No real-time quotes — a reference work, not a trading platform3643companies in the directory 1104ISIN verified against the check digit 7exchanges 14sectors No real-time quotes — a reference work, not a trading platform
DE · EN Newsletter
Biotech & Pharma Symbolbild · KI-generiert
Biotech & Pharma IVQ

Invesque Inc.

Stock factsheet

TickerIVQ
ExchangeTSX
ISIN
WKN
SectorBiotech & Pharma
Size class Micro Cap
Market capitalisation 85 Mio. USD As of 2026-08-04

Company data from public sources (TMX Money, Canadian Securities Exchange, Nasdaq screener, Wikidata); every ISIN is verified against its check digit. Where „—“ appears, no verified value exists — we do not publish unverified identifiers. Market capitalisation is an order of magnitude as of the date shown, not a real-time figure. The size class follows the thresholds in common use (micro < $300m, small < $2bn, mid < $10bn) and is meant as an indication, not a definition.

Company profile

Invesque is a North American health care real estate company with an investment thesis focused on the premise that an aging demographic will continue to utilize health care services in growing proportion to the overall economy. The Company currently capitalizes on this opportunity by investing in a portfolio of income-generating, private pay seniors housing communities. Invesque's portfolio includes investments in independent living, assisted living, and memory care, which are operated under joint venture arrangements with industry-leading operating partners and in owner-occupied seniors housing properties in which the Company owns the real estate, and the licensed operations.

Company description as published by the issuer via TMX Money.

Share price

Price data from TradingView, possibly delayed. Not investment advice.

Comparable companies

Companies in the Biotech & Pharma sector of a similar size.

CompanyTickerExchangeMarket cap
Invesque Inc.IVQ TSX85 Mio. USD
Rallybio RLYBNASDAQ 84 Mio. USD
Zentek Ltd. ZENTSXV 86 Mio. USD
Enablence Technologies Inc. ENATSXV 83 Mio. USD
Jushi Holdings Inc. Class B Subordinate Voting Shares JUSHCSE 83 Mio. USD
HLS Therapeutics Inc. HLSTSX 94 Mio. USD
Grown Rogue International Inc. GRINCSE 94 Mio. USD

Investor Relations

Annual reports Not recorded yet
Investor presentation Not recorded yet
Analyst coverage Not recorded yet

We link only to primary sources from the company itself and from the regulators. Fields we have not recorded stay empty until a reliable source is available.

Information and education only — not investment advice, not a recommendation and not a financial analysis within the meaning of §85 WpHG or Art. 20 MAR. Investments in small and micro caps are highly speculative; total loss is possible. All information without warranty.